Variable | All | CVs | Non- CVs | P a |
---|---|---|---|---|
(n = 145) | (n = 54) | (n = 91) | ||
Men | 113 (77.9 %) | 45 (83.3 %) | 68 (74.7 %) | 0.227 |
Age(years) | 65.2 ± 11.3 | 68.5 ± 10.5 | 63.2 ± 11.5 | 0.006 |
Body mass index(kg/m2) | 23.9 ± 3.2 | 24.5 ± 3.3 | 23.6 ± 3.2 | 0.108 |
History of cardiovascular disease | ||||
Previous myocardial infarction | 26 (17.9 %) | 10 (18.5 %) | 16 (17.6 %) | 0.887 |
Stroke | 3 (2.1 %) | 1 (1.9 %) | 2 (2.2 %) | 0.998 |
Peripheral vascular disease | 5 (3.4 %) | 2 (3.7 %) | 3 (3.3 %) | 0.998 |
Cardiovascular disease risk factors | ||||
Hypertension | 116 (80.0 %) | 48 (88.9 %) | 68 (74.7 %) | 0.039 |
Diabetes mellitus | 65 (44.8 %) | 32 (59.3 %) | 33 (36.3 %) | 0.007 |
Dyslipidemia | 123 (84.8 %) | 46 (85.2 %) | 77 (84.6 %) | 0.926 |
Smoking, current or former | 63 (43.4 %) | 23 (42.6 %) | 40 (44.0 %) | 0.873 |
Family history | 26 (17.9 %) | 12 (22.2 %) | 14 (15.4 %) | 0.299 |
Etiology of CKD | ||||
Diabetes | 40 (27.6 %) | 14 (25.9 %) | 26 (28.6 %) | |
Glomerulonephritis | 22 (15.2 %) | 7 (13.0 %) | 15 (16.5 %) | |
Hypertension | 36 (24.8 %) | 16 (29.6 %) | 20 (22.0 %) | 0.875 |
Polycystic kidney disease | 5 (3.4 %) | 2 (3.7 %) | 3 (3.3 %) | |
Unknown | 42 (29.0 %) | 15 (27.8 %) | 27 (29.7 %) | |
Medication | ||||
Angiotensin receptor blocker | 65 (44.8 %) | 24 (44.4 %) | 41 (45.1 %) | 0.943 |
Angiotensin converting enzyme inhibitors | 27 (18.6 %) | 14 (25.9 %) | 13 (14.4 %) | 0.082 |
Insulin | 7 (4.8 %) | 3 (5.6 %) | 4 (4.4 %) | 0.753 |
Antiplatelet | 71 (48.9 %) | 25 (46.3 %) | 46 (50.6 %) | 0.620 |